Amneal Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge GTLS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges HNI Q1 2026 Earnings EPS Beat Offers Profitability Signal Amid Quiet Revenue Disclosures GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported DRMA Q1 2026 Earnings Narrower Loss Than Expected Bolsters Investor Sentiment